In May this year, a new EU directive came into force which provides that all stick products (syringes, cannulas, catheters, etc.) in Europe must be protected to prevent both patient and personnel from being accidentally exposed to potentially contaminated needle sticks. This was something in which Helsingborg-based Vigmed saw great potential. With its proprietary, patented stick protection it hopes to capture significant market share in this gigantic market. Within the next few days the first product will launch in the form of VigClip, a needlestick protected venous catheter which will initially be marketed in Europe and China.<\/p>\n
They have chosen AMB in Broakulla as business partner and producer of their third needlestick protected product, with the launch planned for 2015. AMB will be responsible for the entire production chain, from purchasing and injection moulding to fully automated cleanroom production and sterilisation. It\u2019s why AMB is now investing more than SEK 30 million, mostly in automated equipment unique to the product.<\/p>\n
\u201cThis investment is fully in line with our strategy to grow in the medical field,\u201d says AMB\u2019s CEO Tomas Magnusson. \u201cWe\u2019re taking another important step towards highly automated, high-volume production of sterile applications, while also showing that we\u2019re competitive in a global perspective.\u201d
\nAMB was also involved in the design phase through its subsidiary, toolmaker Tingverken in Tingsryd, which played an active role in Vigmed\u2019s product development. Vigmed\u2019s CEO Finn Ketler regards AMB as the perfect partner.<\/p>\n
\u201cThrough our partnership with AMB, we will further strengthen our ability to deliver a broad, unique range of products to the market,\u201d he says. \u201cAMB is a perfect complement to the production partnerships we\u2019ve already established in Sweden and India, and is recognised as an experienced high-tech manufacturer of medical devices.\u201d<\/p>\n
For further information, please contact: Tomas Magnusson, CEO of AMB Industri AB, telephone: +46 471 485 18 or +46 70 543 97 90.<\/p>\n
Caption: A handshake worth SEK 30 million Vigmed\u2019s CEO Finn Ketler and AMB\u2019s CEO Tomas Magnusson, flanked by Chairman Lennart Holm and AMB\u2019s KAM H\u00e5kan Lavebratt, at Vigmed\u2019s premises in Helsingborg at contract signing.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" AMB in Broakulla has today entered into a long-term agreement with Vigmed to mass-produce a future sticksafe niche product.<\/p>\n","protected":false},"author":1,"featured_media":4667,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"gallery","meta":{"inline_featured_image":false,"footnotes":""},"categories":[12,17],"tags":[],"class_list":["post-5402","post","type-post","status-publish","format-gallery","has-post-thumbnail","hentry","category-news","category-press-releases","post_format-post-format-gallery"],"yoast_head":"\n